GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research